News About: Pharm. Industry
Kwangdong Implements Total Productive Maintenance Program
Kwangdong Pharmaceutical has implemented a production plant and equipment maintenance concept known as the TPM (Total Productive Maintenance) program, to lead a company-wide recognition and participation towards impro...
DongKoo Achieves $3 Million USD Export Agreement to Taiwan
DongKoo Pharmaceutical announced that it has recently made a $3 million USD export agreement to Taiwan for the current year, surpassing last year's level of $1 million USD from exports to over ten countries worldwide....
Industry Gives Positive Outlook on Increased Domestic OTC Sales
The pharmaceutical industry is making its positive outlook on increased domestic sales activity of over-the-counter (OTC) products, based on a recent announcement by the government to allow for public advertising of c...
Domestic Firm Joins Competitive Market for Anti-Hypertension Treatments
The pharmaceutical industry expects an elevated level of competition in the domestic ARB (angiotensin II receptor blocker) hypertension treatment market currently predominated by foreign-invested firms, with an introd...
LG Life Sciences Sets Revenue Plan at 230 Billion Won
LG Life Sciences Ltd. recently announced that its total revenue plan for Year 2005 is finally set at 230 billion won, up 7.7% from the prior year, reflective of the company's competitive product lineups and their plan...
Novel Liver Support System for Improving Survival Rate Under Development
Lifecord Co., a domestic company specialized in the cord blood storage, is currently undertaking a joint development project of the hepatocyte-based liver support system for patients with acute hepatic failures, with ...
GSK Korea's Establishment of Vaccine Production Facility Still Under Discussion
In reaction to a number of reports recently made by the domestic daily newspapers that GlaxoSmithKline (GSK) Korea would establish a large-scale vaccine production facility in the Gyeonggi province, the company stated...
Existing OTC Products with Renewed Versions to Attract More Demands
The domestic pharmaceutical firms are attempting to increase their over-the-counter (OTC) product sales by renewing the existing products with added ingredients and different packaging formats.
Given that the sales...
Kolmar Korea Ventures Into Oriental Medicine and Natural Remedies
Under a strategic objective to develop novel pharmaceutical and cosmetic products by utilizing natural ingredients and their efficacies derived from Chinese traditional medicines, Kolmar Korea has recently added two p...
Removal of Novarsc by Domestic Hospital
An industry source reported last week that the Severance Hospital Group has removed Pfizer Korea's Novarsc, an anti-hypertension drug, from its available group of prescription-based treatments.
According to the sou...
